Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
Broadwood Partners, L.P. bought 570,184 Insight Molecular Diagnostics Inc. shares (Form 4)
Traded Apr 23 to Apr 27, 2026 · Filed Apr 27, 2026
From Apr 23 to Apr 27, 2026, Broadwood Partners, L.P. (10% owner) bought 570,184 Insight Molecular Diagnostics Inc. shares at an average US$3.56 for US$2.03M, leaving 12,684,884 shares. Filed Apr 27, 2026 (Form 4).
- Bought
- 570,184 shares
- Price
- US$3.56 average (US$3.50 to US$3.64)
- Value
- US$2.03M
- Holding after
- 12,684,884 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock, no par value | Buy | 280,381 | US$3.50 | 12,395,081 | Direct |
| Apr 23, 2026 | Common Stock, no par value | Buy | 0 | 12,395,081 | Indirect | |
| Apr 24, 2026 | Common Stock, no par value | Buy | 38,880 | US$3.53 | 12,433,961 | Direct |
| Apr 24, 2026 | Common Stock, no par value | Buy | 0 | 12,433,961 | Indirect | |
| Apr 27, 2026 | Common Stock, no par value | Buy | 250,923 | US$3.64 | 12,684,884 | Direct |
| Apr 27, 2026 | Common Stock, no par value | Buy | 0 | 12,684,884 | Indirect |